Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells
- 21 May 2014
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (8) , 8169-8178
Abstract
Solamargine (SM), a major steroidal alkaloid glycoside extracted from a traditional Chinese medicinal herb, Solanum nigrum L. (SNL), has been shown to inhibit growth and induce apoptosis of various cancer cells. However, the molecular mechanisms underlying this are poorly understood. In this study, we showed that SM inhibited growth and induced apoptosis of non-small-cell lung cancer (NSCLC) cells in a time- and dose-dependent manner. To further explore this, we found that SM increased phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) in a time-dependent fashion. SM also inhibited phosphorylation and protein expression of signal transducer and activator of transcription 3 (Stat3), a transcription factor, which was abrogated by the SB203580, a specific inhibitor of p38 MAPK. In addition, SM induced protein expression of p21, one of cyclin-dependent kinase inhibitors, and this was not observed in cell overexpression of Stat3 or cells treated with SB203580. Finally, while silencing of Stat3 had no further effect, exogenous expression of Stat3 overcame the effect of SM on cell proliferation. Collectively, our results show that SM inhibits proliferation and induces apoptosis in lung cancer cells through p38 MAPK-mediated suppression of phosphorylation and protein expression of Stat3, followed by inducing Stat3 downstream effector p21. This unveils a potential new mechanism by which SM inhibits growth of human lung cancer cells.Keywords
This publication has 29 references indexed in Scilit:
- Hyperosmotic stress sustains cytokine-stimulated phosphorylation of STAT3, but slows its nuclear trafficking and impairs STAT3-dependent transcriptionCellular Signalling, 2014
- A novel compound RY10-4 induces apoptosis and inhibits invasion via inhibiting STAT3 through ERK-, p38-dependent pathways in human lung adenocarcinoma A549 cellsChemico-Biological Interactions, 2014
- STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cellsBritish Journal of Cancer, 2013
- STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cellsCellular Signalling, 2013
- Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3Cancer Biology & Therapy, 2012
- Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells.2011
- P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatmentBiomedicine & Pharmacotherapy, 2011
- Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cellsLife Sciences, 2011
- Targeted therapies for non-small cell lung cancerLung Cancer, 2010
- Action of solamargine on TNFs and cisplatin-resistant human lung cancer cellsBiochemical and Biophysical Research Communications, 2004